Meanings of average survival in English

Glioblastoma patients have an average survival time of less than 15 months.

Once melanoma spreads, the average survival is typically six to nine months.

Among similar children treated with ECMO, the average survival was just 10 days.

The average survival time is one to two years.

Even with the improved therapy regimen including temozolomide, the average survival rate is less than 2 years.

Bleaching and mortality decline with depth, and some sites and reefs had much better than average survival.

The prognosis of high-grade oligodendroglioma has been reported poor with an average survival of approximately 17 months.

With conventional treatment, the average survival time ranges from 10 to 18 months.

In spite of aggressive antitumoral treatment, the course was disastrous with an average survival of 13.6 days.

The average survival time of less than 1 year has not improved notably over the last 3 decades.

Studies have shown that when very ill lung-cancer patients were given a common chemotherapy, the average survival was half that of stronger patients.

Patients with advanced forms of primary myelofibrosis (PMF) have an average survival of 4 to 5 years.

Twenty-four descendants were naturally born, average reproduction rate was 38.7%, and average survival rate of foals was 69.1% in this interim.

Average survival times were 7.3 months with interferon alfa and 8.4 months with the combination, which is not a significant difference.